John Wayne Cancer Institute Biocept, Providence Saint Joseph's Health Center Collaborate on CSF Liquid Biopsy Testing Biocept will use its liquid biopsy assay to test cerebrospinal fluids of patients diagnosed with certain cancers and then compare results to standard methods. UPDATE: HTG, John Wayne Cancer Institute Partner on Melanoma Assays This article has been updated with comments from HTG's CEO and additional background information. IP Watch: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep: Mar 23, 2011 Premium Roche, Toshiba, Sekisui Medical, Complete Genomics, Orion Genomics, JWCI, and Norchip are awarded US patents. John Wayne Cancer Institute Receives $1M Grant from Abraxis The gift will support JWCI's search for genes and proteins that can serve as biomarkers for solid-tumor cancers, and to develop new biomarker-specific blood tests for cancer. Breaking News Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.